Degeneration of photoreceptors is a common feature of ciliopathies, owing to the importance of the specialized ciliary structure of these cells. Mutations in AHI1, which encodes a cilium-localized protein, have been shown to cause a form of Joubert syndrome that is highly penetrant for retinal degeneration 1,2 . We show that Ahi1-null mice fail to form retinal outer segments and have abnormal distribution of opsin throughout their photoreceptors. Apoptotic cell death of photoreceptors occurs rapidly between 2 and 4 weeks of age in these mice and is significantly (P = 0.00175 and 0.00613) delayed by a reduced dosage of opsin. This phenotype also shows dosage-sensitive genetic interactions with Nphp1, another ciliopathy-related gene. Although it is not a primary cause of retinal blindness in humans, we show that an allele of AHI1 is associated with a more than sevenfold increase in relative risk of retinal degeneration within a cohort of individuals with the hereditary kidney disease nephronophthisis. Our data support context-specific roles for AHI1 as a contributor to retinopathy and show that AHI1 may explain a proportion of the variability in retinal phenotypes observed in nephronophthisis.
Ciliopathies comprise an increasingly diverse group of genetic disorders, unified by their connection to dysfunction of the primary cilium and/or its associated basal body 3 . Because of the pervasiveness of this organelle, these disorders manifest in numerous organs. Joubert syndrome (characterized by cerebellar hypoplasia), Leber's congenital amaurosis (LCA, characterized by congenital retinal blindness) and nephron ophthisis (NPHP, characterized by fibrocystic renal disease) each primarily affect one of three organs frequently diseased in ciliopathies, namely the cerebellum, retina and kidney. These diseases are geneti cally heterogeneous and are sometimes variable even within single families, undermining the predictive value of diagnostics and genetic counseling. Though many causative genes have been identified for these Mendelian disorders, our current understanding of the underly ing genetics and mechanisms is insufficient to explain this variability and suggests the involvement of genetic modifiers.
Mutations in AHI1 are identified in 12% of individuals with Joubert syndrome and 20% of individuals with both Joubert syndrome and LCA 1, 2, 4, 5 , though AHI1 mutations are not known to cause non syndromic LCA. The protein AHI1, or jouberin, contains an Nterminal coiledcoil region, seven WD40 repeats and an SH3 domain 6 ; AHI1 also interacts with nephrocystin1 (NPHP1) 7 , the product of the gene that is the most commonly mutated in juvenile NPHP 8,9 . To study the role of AHI1 in disease pathogenesis, we generated targeted con ditional and null alleles of mouse Ahi1, flanking exons 6-7 with loxP sequences (Supplementary Fig. 1a,b ). Homozygous germline mutants (Ahi1 −/− ) were runted and showed high mortality ( Supplementary  Fig. 1c,d) . Brain morphology was grossly preserved, and neuronal specific NestinCre conditional knockouts (Ahi1 NestinCre cKO) AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis 1 7 6 volume 42 | number 2 | february 2010 Nature GeNetics l e t t e r s showed nearly Mendelian ratios at weaning age (data not shown), suggesting that effects outside of the nervous system influence the survival of Ahi1 −/− mice.
Histological analysis of the retina showed rapid loss of the outer nuclear (photoreceptor) layer, with few nuclei remaining by age 1 month in Ahi1 −/− mice ( Fig. 1a) . As early as postnatal day (P) 10, transmission electron microscopy showed a complete absence of both rod and cone outer segments (specialized diskshaped membranes of photoreceptor cilia; Fig. 1b and Supplementary Fig. 2a ). This far preceded the initiation of apoptotic cell death, which was apparent by ~3 weeks of age as indicated by activated caspase3 expression ( Fig. 1c) . Photoreceptor ciliary axonemes were intact and had normal 9 + 0 microtubule doublet configuration ( Fig. 1b and Supplementary  Fig. 2b ), arguing against a role for Ahi1 in axonemal development. Darkadapted electroretinograms (ERG) from Ahi1 NestinCre cKO and Ahi1 +/control mice preceding cell loss confirmed absence of electrical activity ( Fig. 1d) . Consistent with its putative role in cilia function, we found that Ahi1 was enriched at the connecting cilium and basal body and overlapped with expression of a Cetn2 (centrin 2, a centriole-transition zone marker 10, 11 ) transgene ( Fig. 1e ). This expression pattern was reminiscent of those for ciliary transport mol ecules such as Ift88 (ref. 12 ) and other ciliopathyassociated molecules such as Nphp1 (ref. 13 ). Together, these results reveal specific defects of outer segment morphogenesis and photoreceptor survival associ ated with absence of Ahi1.
Rhodopsin (rod opsin and cofactor, retinal), which is responsible for initiating the first steps in lightdependent signal transduction, is also necessary for outer segment formation [14] [15] [16] [17] . Disruptions of genes required for ciliary transport result in mislocalized opsin and outer segment defects 12, [18] [19] [20] , which prompted us to assess opsin localiza tion in Ahi1 −/− retina. We found severely disturbed opsin distribution as early as P10 ( Fig. 2a) . We quantified this in immunogoldlabeled sections, which showed significantly increased inner segment labeling in mutants, both in the cytoplasm and particularly along inner segment plasma membranes compared to controls ( Fig. 2b and Supplementary Fig. 2c ). This difference was ~10fold for both the inner segment and plasma membrane (P = 8.0 × 10 −6 and P = 2.2 × 10 −7 , respectively). Some other proteins implicated in outer segment morphogenesis appeared grossly intact ( Supplementary Fig. 2d ). We conclude that opsin is significantly misaccumulated in Ahi1 −/− mice at an early stage of outer segment morphogenesis.
To further test for celltype-specific requirements for Ahi1 in opsin distribution, we used Ahi1 flox/flox mice in a series of retinal in vivo electroporation experiments performed at P0 ( Supplementary Fig. 3a ). The pCAGCre:GFP vector drives Cre:GFP under the constitutive chick βactin promoter and was used with the CALNLpDsRed recombina tion reporter 21, 22 . Photoreceptors with evidence of Cre recombina tion based upon expression of DsRed also showed recapitulation of the opsin redistribution phenotype by age 1 month ( Supplementary  Fig. 3b) , indicating a requirement for Ahi1 in photoreceptors. To test for temporalspecific requirements for Ahi1, these experiments were repeated using the vector pCAGERT2CreERT2, which activates Cre under control of 4hydroxytamoxifen (4OHT) 22 . Following 4OHT dosage at P14, after the peak of outer segment development, we did not detect opsin accumulation at 2 and 4 weeks after Cre induction, despite evidence of recombination based upon expression of DsRed (n = 2, Supplementary Fig. 3c,d) . We conclude that Ahi1 shows temporal specificity in its function in photoreceptors, possibly akin to the time dependence reported for ciliary transport machinery in kidney phenotypes 23 . These data also suggest that other factors might contribute to outer segment developmental defects in this model.
Mislocalized opsin is frequently associated with retinal degenera tion in animal models 19, 24 
Ac-tubulin l e t t e r s accumulation of opsin in Ahi1 −/− mice, we hypothesized that this might similarly contribute to cell death in Ahi1 −/− photoreceptors. To test this directly, we reduced opsin levels in Ahi1 −/− mice by introduc ing a Rho (rod opsin)null allele 15 into the Ahi1 −/− background. Rho +/− photoreceptors have approximately 40%-50% reduction in opsin content 15, 25 . Reduction in opsin dosage did not affect outer segment formation, with similar absence of outer segments in Ahi1 −/− Rho +/− compared to Ahi1 −/− mice (Supplementary Fig. 4 ), but it significantly delayed the cell loss seen in Ahi1 −/− mice. We found nearly complete rescue of cell numbers at 3 weeks of age (n = 3-7, P = 0.00175) and partial rescue at 1 month ( Fig. 3 ; n = 3-4, P = 0.00613). These data support the hypothesis that abnormal accumulation of opsin contributes to the loss of Ahi1 −/− photoreceptors. Mutations in NPHP1 cause juvenile neph ronophthisis with partially penetrant retino pathy. To study Nphp1 in mouse, we generated a targeted disruption of Nphp1 by insertion of a neobpA cassette into exon 4, which gen erated a null allele and confirmed absence of Nphp1 expression (Supplementary Fig. 5a-c) . The photoreceptors of Nphp1 neo/neo mice (hereafter denoted as Nphp1 −/− ) formed outer segments but underwent gradual retinal degeneration, which was slightly evident at 2 months (Supplementary Fig. 5d ). This was milder than an independently targeted Nphp1 mutant reported to show failure of outer seg ment formation followed by retinal degen eration 26 . Because both Nphp1 alleles are predicted to function as nulls, this difference in severity of retinal phenotypes suggests the influence of genetic modifiers.
To test whether genetic interaction between Ahi1 and Nphp1 can influence phenotypic expression in vivo, we examined double mutant combinations of Ahi1 and Nphp1 alleles, ranging from single heterozygotes to knockoutheterozygote combinations, for outer nuclear layer (ONL) thickness and for mislo calized opsin. To efficiently obtain Ahi1 homozygous null genotypes, we used the Ahi1 flox allele and the distal (peripheral) retinaspecific Pax6αCre transgene 27 to circumvent the lethality associated with Ahi1 −/− . We observed trends of increasing severity of cell loss and opsin redistribution with additional deleterious alleles with the Ahi1 null allele showing a stronger effect (Fig. 4a) . Specifically, we found significantly decreased ONL thickness and increased ONLlocalized (Fig. 4b) . These data suggest that dosagesensitive genetic interactions occur between Ahi1 and Nphp1 in retinal development.
Based on the pronounced retinopathy in Ahi1 −/− mice, we next tested whether AHI1 was mutated in humans with isolated LCA. In a screen of AHI1coding exons from wellcharacterized individu als with LCA (from the United States, Canada, The Netherlands and Spain, prescreened for mutations in known LCA genes; n = 176), no homozygous or compound heterozygous deleterious changes were identified. However, one variant, R830WC2488T, heterozygous in nine independent cases, was of particular interest, though it was not significantly enriched in affected individuals compared to con trols (data not shown). Arg830 is conserved throughout vertebrate homologs, and in addition, a change from arginine to tryptophan (from a polar basic residue to a nonpolar hydrophobic residue) is predicted to be damaging to AHI1 (Polyphen 28 and SNPs3D 29 ). This, coupled with its position within the WD40 repeat domain (between two blades of its predicted propeller structure; Supplementary  Fig. 6a,b) , suggested that this substitution might interfere with the function of AHI1, perhaps in proteinprotein interactions.
To test whether this change altered sedimentation of AHI1 com plexes in vitro, we expressed GFPAHI1 with the R830W substitu tion, wildtype GFPAHI1 or GFPEV (empty vector) in cells from the HEK293T line with untagged human rhodopsin 30 (RHO) and assayed lysates by sucrose density gradients (Supplementary Fig. 6c ). We identified two distinct sedimentation peaks containing AHI1 that appeared at lower intensity for GFPAHI1 R830W-transfected cells; this decrease suggests underrepresentation of AHI1 R830W in complexes, despite comparable total expression levels of AHI1 R830W and wildtype AHI1 or emptyvector controls in HEK293T cells (Supplementary Fig. 6d ). Furthermore, opsin was shifted toward lowerdensity complexes in cells expressing AHI1 R830W compared to those expressing wildtype AHI1 or empty vector. This lends support to potentially hypomorphic effects of R830W, perhaps in complex stability or formation. This variant has been mentioned as a polymorphism in several AHI1 studies 1,2,31,32 , but the effect of the change on retinal disease has not been explored. Due to the genetic interaction of Ahi1 and Nphp1 in mice and the variable association of retinal degeneration with nephronophthisis (also known as Senior Løken syndrome, SLSN 33 ), we hypothesized that AHI1 R830W might contribute to the risk of retinopathy in nephronophthisis patients.
We thus genotyped 153 independent individuals with nephro nophthisis from Italy (of which 16 had retinal degeneration) and 306 ethnically matched healthy controls for the R830W (C2488T) change. We found that the Tallele frequency was significantly higher in individuals with NPHP and retinal degeneration versus those with NPHP excluded for retinal degeneration (25% compared to 1.8%, P = 5.36 × 10 −6 , Table 1 ) and versus controls (25% compared to 2.8%, P = 9.03 × 10 −6 ; Table 1 ). This translated to a relative risk of 7.5 (95% CI 4.0-11.2) associated with AHI1 R830W for retinal degenera tion within NPHP patients. To determine if this association depended upon the primary gene mutation, we repeated this analysis after subdividing affected individuals into those with NPHP1 mutations (either homozygous or compound heterozygous mutation) versus those without NPHP1 mutations. AHI1 R830W continued to be sig nificantly associated with NPHP in the presence of retinal degenera tion irrespective of the primary mutation ( Table 1) .
To control for population stratification, we also examined transmission of R830W in this cohort 34 by genotyping parents of 117 available trios. We found 17 informative trios where one parent was heterozygous for C2488T. Although this sample size was too limited for full transmission disequilibrium test analysis, we found that the T allele was overtransmitted to individuals with both NPHP and retinal degeneration. Specifically, the T allele was transmitted 100% of the time to individuals with NPHP and retinal degenera tion (n = 7, P < 0.01, χ 2 test) but only 50% of the time to individuals with NPHP without retinal degeneration (n = 10, no significant l e t t e r s difference from the null hypothesis). This association was apparent when evaluating single families; for example, in one family with three individuals with NPHP 33 , AHI1 R830W segregated only with the sibling showing an absent ERG response, whereas the other siblings retained visual function. Our results support a role for AHI1 as a modifier of retinal degeneration in the context of mutations leading to NPHP. That this AHI1 allele is associated with retinal disease in as many as half of individuals with SLSN in this Italian population suggests that other, rarer AHI1 variants may behave similarly. Results from the mouse models support a role for Ahi1 in ciliaassociated trafficking mechanisms, consistent with the results of a recent study describing Ahi1 function in cultured cells 35 . We also identify a new role for Ahi1 in photoreceptor development and demonstrate the utility of mouse genetic interaction studies in identifying loci conferring highrisk alleles for disease. A similar effect was reported for one variant of RPGRIP1L 36 , supporting the role of modifiers in phenotypic expres sivity of ciliopathies. Given the complexity of ciliopathy phenotypes, it is likely that other variable phenotypes could also be explained by genetic modifiers. Notably, a cohort of individuals with Joubert syndrome (n = 155) did not reveal a significant difference in fre quency of AHI1 R830W, although R830W was found with slightly higher frequency in affected individuals relative to controls. These individuals were ascertained for having phenotypes associated with a specific constellation of midbrainhindbrain malformations but also for having variably present renal and/or retinal dysfunction. Lack of significant association with Joubert syndrome may reflect more complex interactions at the molecular level, requiring specific disruptions to alter phenotypic expression. Future screenings at other loci may help elucidate these distinct but overlapping mechanisms.
Our example within the ciliopathies shows that mutational analysis of other causative genes from the broader clinical spectrum can yield substantial insight into the genetics and pathogenesis of hetero geneous syndromic disorders.
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